Literature DB >> 34992284

Restoration of established systemic inflammation and autoimmunity by Foxp3+ regulatory T cells.

Varun Kumar Sharma1, Jagadeesh Bayry2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34992284      PMCID： PMC8803871          DOI： 10.1038/s41423-021-00831-4

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  15 in total

1.  A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism.

Authors:  Eleonora Trotta; Paul H Bessette; Stephanie L Silveria; Lauren K Ely; Kevin M Jude; Duy T Le; Charles R Holst; Anthony Coyle; Marc Potempa; Lewis L Lanier; K Christopher Garcia; Natasha K Crellin; Isaac J Rondon; Jeffrey A Bluestone
Journal:  Nat Med       Date:  2018-06-25       Impact factor: 53.440

2.  Regulatory T cells induce activation rather than suppression of human basophils.

Authors:  Meenu Sharma; Mrinmoy Das; Emmanuel Stephen-Victor; Caroline Galeotti; Anupama Karnam; Mohan S Maddur; Patrick Bruneval; Srini V Kaveri; Jagadeesh Bayry
Journal:  Sci Immunol       Date:  2018-05-25

3.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

4.  Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

Authors:  Mary E Morgan; Jolanda H M van Bilsen; Aleida M Bakker; Bianca Heemskerk; Marco W Schilham; Franca C Hartgers; Berendina G Elferink; Linda van der Zanden; René R P de Vries; Tom W J Huizinga; Tom H M Ottenhoff; René E M Toes
Journal:  Hum Immunol       Date:  2005-01       Impact factor: 2.850

5.  Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.

Authors:  Haruhiko Yagi; Takashi Nomura; Kyoko Nakamura; Sayuri Yamazaki; Toshio Kitawaki; Shohei Hori; Michiyuki Maeda; Masafumi Onodera; Takashi Uchiyama; Shingo Fujii; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2004-10-04       Impact factor: 4.823

6.  Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Authors:  Michelle Rosenzwajg; Roberta Lorenzon; Patrice Cacoub; Hang Phuong Pham; Fabien Pitoiset; Karim El Soufi; Claire RIbet; Claude Bernard; Selim Aractingi; Beatrice Banneville; Laurent Beaugerie; Francis Berenbaum; Julien Champey; Olivier Chazouilleres; Christophe Corpechot; Bruno Fautrel; Arsène Mekinian; Elodie Regnier; David Saadoun; Joe-Elie Salem; Jérémie Sellam; Philippe Seksik; Anne Daguenel-Nguyen; Valérie Doppler; Jéremie Mariau; Eric Vicaut; David Klatzmann
Journal:  Ann Rheum Dis       Date:  2018-11-24       Impact factor: 19.103

Review 7.  Interleukin-2 and regulatory T cells in rheumatic diseases.

Authors:  Antonios G A Kolios; George C Tsokos; David Klatzmann
Journal:  Nat Rev Rheumatol       Date:  2021-11-02       Impact factor: 20.543

Review 8.  Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.

Authors:  Marco Romano; Giorgia Fanelli; Caraugh Jane Albany; Giulio Giganti; Giovanna Lombardi
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

9.  Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.

Authors:  Marc Permanyer; Berislav Bošnjak; Silke Glage; Michaela Friedrichsen; Stefan Floess; Jochen Huehn; Gwendolyn E Patzer; Ivan Odak; Nadine Eckert; Razieh Zargari; Laura Ospina-Quintero; Hristo Georgiev; Reinhold Förster
Journal:  Cell Mol Immunol       Date:  2021-01-06       Impact factor: 22.096

10.  Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity.

Authors:  Wei Hu; Zhong-Min Wang; Yongqiang Feng; Michail Schizas; Beatrice E Hoyos; Joris van der Veeken; Jacob G Verter; Regina Bou-Puerto; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2021-08-23       Impact factor: 31.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.